GB201006324D0 - Vaccine - Google Patents
VaccineInfo
- Publication number
- GB201006324D0 GB201006324D0 GBGB1006324.6A GB201006324A GB201006324D0 GB 201006324 D0 GB201006324 D0 GB 201006324D0 GB 201006324 A GB201006324 A GB 201006324A GB 201006324 D0 GB201006324 D0 GB 201006324D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0013—Therapeutic immunisation against small organic molecules, e.g. ***e, nicotine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1006324.6A GB201006324D0 (en) | 2010-04-15 | 2010-04-15 | Vaccine |
PCT/EP2010/058328 WO2011127989A1 (en) | 2010-04-15 | 2010-06-14 | Nicotine conjugate vaccine |
CN2010102702104A CN102218137A (en) | 2010-04-15 | 2010-06-15 | Vaccine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1006324.6A GB201006324D0 (en) | 2010-04-15 | 2010-04-15 | Vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201006324D0 true GB201006324D0 (en) | 2010-06-02 |
Family
ID=42245280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1006324.6A Ceased GB201006324D0 (en) | 2010-04-15 | 2010-04-15 | Vaccine |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN102218137A (en) |
GB (1) | GB201006324D0 (en) |
WO (1) | WO2011127989A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10093947B2 (en) * | 2012-02-28 | 2018-10-09 | Cornell University | AAV-directed persistent expression of an anti-nicotine antibody gene for smoking cessation |
US10004811B2 (en) * | 2012-04-13 | 2018-06-26 | Cornell University | Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0382271B1 (en) | 1989-02-04 | 1994-12-21 | Akzo Nobel N.V. | Tocols as adjuvant in vaccine |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
US5876727A (en) | 1995-03-31 | 1999-03-02 | Immulogic Pharmaceutical Corporation | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
SE9801923D0 (en) | 1998-05-29 | 1998-05-29 | Independent Pharmaceutical Ab | Nicotine vaccine |
US6232082B1 (en) | 1998-12-01 | 2001-05-15 | Nabi | Hapten-carrier conjugates for treating and preventing nicotine addiction |
JP5084103B2 (en) | 2002-07-18 | 2012-11-28 | サイトス バイオテクノロジー アーゲー | Hapten carrier conjugates and uses thereof |
WO2009120954A2 (en) * | 2008-03-27 | 2009-10-01 | The Scripps Research Institute | Nicotine immunoconjugates |
-
2010
- 2010-04-15 GB GBGB1006324.6A patent/GB201006324D0/en not_active Ceased
- 2010-06-14 WO PCT/EP2010/058328 patent/WO2011127989A1/en active Application Filing
- 2010-06-15 CN CN2010102702104A patent/CN102218137A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2011127989A1 (en) | 2011-10-20 |
CN102218137A (en) | 2011-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201005005D0 (en) | New vaccine | |
IL223206A0 (en) | Vaccine formulations | |
IL217008A0 (en) | Vaccine | |
GB201015132D0 (en) | Vaccine composition | |
IL231043A0 (en) | Vaccine | |
ZA201300395B (en) | Influenza vaccine | |
GB201006165D0 (en) | Vaccine | |
GB201119999D0 (en) | Vaccine | |
ZA201301950B (en) | Bvdv vaccine | |
GB201003293D0 (en) | Cancer vaccine | |
EP2543387A4 (en) | Mucosal vaccine | |
GB201001726D0 (en) | Bunyavirus vaccine | |
EP2763699A4 (en) | Vaccine | |
GB201014965D0 (en) | Vaccine | |
GB201000522D0 (en) | Vaccine | |
GB201013006D0 (en) | Vaccine | |
GB201006324D0 (en) | Vaccine | |
GB201120000D0 (en) | Vaccine | |
IL217194A0 (en) | Vaccine | |
ZA201302154B (en) | Vaccine | |
GB201012283D0 (en) | Vaccine | |
GB201007588D0 (en) | Vaccine | |
GB201007589D0 (en) | Vaccine | |
GB201008786D0 (en) | Vaccines | |
GB201008795D0 (en) | Vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |